Amalgamated Bank Sells 3,796 Shares of The Clorox Company (NYSE:CLX)

Amalgamated Bank lessened its holdings in shares of The Clorox Company (NYSE:CLX) by 12.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,821 shares of the company’s stock after selling 3,796 shares during the period. Amalgamated Bank’s holdings in Clorox were worth $4,107,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of CLX. Choreo LLC boosted its stake in Clorox by 12.8% during the 4th quarter. Choreo LLC now owns 5,741 shares of the company’s stock valued at $819,000 after purchasing an additional 652 shares during the last quarter. abrdn plc increased its stake in Clorox by 20.1% in the 4th quarter. abrdn plc now owns 198,250 shares of the company’s stock worth $28,268,000 after buying an additional 33,135 shares in the last quarter. Savoir Faire Capital Management L.P. lifted its holdings in Clorox by 61.8% in the 4th quarter. Savoir Faire Capital Management L.P. now owns 65,192 shares of the company’s stock worth $9,296,000 after purchasing an additional 24,897 shares in the last quarter. Victory Capital Management Inc. boosted its position in shares of Clorox by 3.9% during the fourth quarter. Victory Capital Management Inc. now owns 172,526 shares of the company’s stock worth $24,600,000 after acquiring an additional 6,510 shares during the last quarter. Finally, International Assets Investment Management LLC lifted its position in shares of Clorox by 17,658.5% in the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after buying an additional 481,725 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Jefferies Financial Group raised Clorox from an “underperform” rating to a “hold” rating and set a $145.00 target price on the stock in a research note on Tuesday, March 26th. The Goldman Sachs Group initiated coverage on shares of Clorox in a research report on Friday, March 1st. They set a “sell” rating and a $140.00 target price for the company. JPMorgan Chase & Co. lowered their price target on Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Morgan Stanley reissued an “equal weight” rating and issued a $160.00 price objective on shares of Clorox in a report on Tuesday, March 26th. Finally, DA Davidson reissued a “neutral” rating and set a $162.00 target price on shares of Clorox in a report on Wednesday, April 17th. Four analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $146.43.

Clorox Stock Performance

NYSE:CLX traded up $0.24 during trading hours on Friday, reaching $131.53. 805,706 shares of the company’s stock were exchanged, compared to its average volume of 1,470,166. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $169.14. The firm has a market capitalization of $16.33 billion, a price-to-earnings ratio of 68.15, a P/E/G ratio of 2.03 and a beta of 0.44. The company has a 50-day moving average of $143.83 and a 200 day moving average of $144.89. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. The company had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 302.49%. Clorox’s quarterly revenue was down 5.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.51 EPS. Research analysts anticipate that The Clorox Company will post 5.83 EPS for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th were given a dividend of $1.20 per share. The ex-dividend date of this dividend was Tuesday, April 23rd. This represents a $4.80 annualized dividend and a yield of 3.65%. Clorox’s payout ratio is currently 248.71%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.